Northwestern University - Chicago, Chicago, IL.

The Minder implantable EEG system. [Image courtesy of Epiminder] Epiminder announced today that it received FDA de novo authorization for its implantable continuous electroencephalogram monitoring ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

March 28, 2025 /PRNewswire/ -- Today, Visby Medical™, a leading innovator in medical diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ...

Objectives The pandemic caused by the new coronavirus (COVID-19) has changed care activities of health professionals. We analysed the possible association between the appearance of ‘de novo’ headache ...

Children have increased risks for new onset mild-to-moderate CKD for at least 2 years after the acute phase of SARS-CoV-2 infection. Children infected with SARS-CoV-2 who develop COVID-19 are more ...

Institute of Bioengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027 Zhejiang, China ...

A study is warranted to quantify the risks for any neurosurgical indication. In this unselected register-based nationwide cohort study with virtually complete follow-up, the short-term and long-term ...

Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, NSW 2145, Australia Sydney Institute for Infectious Diseases, Faculty of Medicine and Health, ...

嘌呤小体包含参与从头嘌呤合成（de novo purine synthesis）的酶，糖酵解体则包含参与糖酵解（glycolysis）的酶。它们形成的一个共同机制是缺氧反应（hypoxic response），嘌呤小体最初是在嘌呤缺乏的情况下被发现的。这表明细胞能够根据环境变化，通过形成这些凝聚 ...

Search for other works by this author on: ...